These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 16007640)

  • 21. Induced expression of syndecan-1 in the stroma of head and neck squamous cell carcinoma.
    Mukunyadzi P; Liu K; Hanna EY; Suen JY; Fan CY
    Mod Pathol; 2003 Aug; 16(8):796-801. PubMed ID: 12920224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The "Brescia panel" (Claudin-4 and BRCA-associated protein 1) in the differential diagnosis of mesotheliomas with epithelioid features versus metastatic carcinomas.
    Bernardi L; Bizzarro T; Pironi F; Szymczuk S; Buda R; Fabbri E; Di Claudio G; Rossi G
    Cancer Cytopathol; 2021 Apr; 129(4):275-282. PubMed ID: 33045147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Podoplanin as a marker for mesothelioma.
    Kimura N; Kimura I
    Pathol Int; 2005 Feb; 55(2):83-6. PubMed ID: 15693854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. D2-40 and podoplanin are highly specific and sensitive immunohistochemical markers of epithelioid malignant mesothelioma.
    Ordóñez NG
    Hum Pathol; 2005 Apr; 36(4):372-80. PubMed ID: 15891998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunocytochemical panel for distinguishing between carcinoma and reactive mesothelial cells in body cavity fluids.
    Politi E; Kandaraki C; Apostolopoulou C; Kyritsi T; Koutselini H
    Diagn Cytopathol; 2005 Mar; 32(3):151-5. PubMed ID: 15690338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Syndecan-1 expression in different soft tissue tumours.
    Orosz Z; Kopper L
    Anticancer Res; 2001; 21(1B):733-7. PubMed ID: 11299835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Syndecan-1 expression--a novel prognostic marker in pancreatic cancer.
    Juuti A; Nordling S; Lundin J; Louhimo J; Haglund C
    Oncology; 2005; 68(2-3):97-106. PubMed ID: 15886501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The level of syndecan-1 expression is a distinguishing feature in behavior between keratoacanthoma and invasive cutaneous squamous cell carcinoma.
    Mukunyadzi P; Sanderson RD; Fan CY; Smoller BR
    Mod Pathol; 2002 Jan; 15(1):45-9. PubMed ID: 11796840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical expression of osteopontin in epithelioid mesotheliomas and reactive mesothelial proliferations.
    Tigrani DY; Weydert JA
    Am J Clin Pathol; 2007 Apr; 127(4):580-4. PubMed ID: 17369133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The diagnostic utility of D2-40 for malignant mesothelioma versus pulmonary carcinoma with pleural involvement.
    Saad RS; Lindner JL; Lin X; Liu YL; Silverman JF
    Diagn Cytopathol; 2006 Dec; 34(12):801-6. PubMed ID: 17115439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Podoplanin is a better immunohistochemical marker for sarcomatoid mesothelioma than calretinin.
    Padgett DM; Cathro HP; Wick MR; Mills SE
    Am J Surg Pathol; 2008 Jan; 32(1):123-7. PubMed ID: 18162779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of a 130-kDa mesothelial and ciliated cell Ag (MCp130) in normal and developing human and rat lung and its role as a diagnostic marker for mesotheliomas and tumors of the female reproductive system.
    Singh G; Singh J; Ordónez NG; Kasper M; Katyal SL; Wong-Chong ML; McCloskey CA
    Lab Invest; 1995 Jul; 73(1):48-58. PubMed ID: 7603040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utility of glucose transporter 1 in the distinction of benign and malignant thoracic and abdominal mesothelial lesions.
    Lagana SM; Taub RN; Borczuk AC
    Arch Pathol Lab Med; 2012 Jul; 136(7):804-9. PubMed ID: 22742553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma cells in chronic endometritis are easily identified when stained with syndecan-1.
    Bayer-Garner IB; Korourian S
    Mod Pathol; 2001 Sep; 14(9):877-9. PubMed ID: 11557783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differentiation of mesothelioma cells is influenced by the expression of proteoglycans.
    Dobra K; Andäng M; Syrokou A; Karamanos NK; Hjerpe A
    Exp Cell Res; 2000 Jul; 258(1):12-22. PubMed ID: 10912783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of the monoclonal antibody MOC-31 as an immunomarker for detecting metastatic adenocarcinoma in effusion cytology.
    Kundu UR; Krishnamurthy S
    Cancer Cytopathol; 2011 Aug; 119(4):272-8. PubMed ID: 21732548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urothelial carcinoma with plasmacytoid variants producing both human chorionic gonadotropin and carbohydrate antigen 19-9.
    Shimada K; Nakamura M; Ishida E; Konishi N
    Urology; 2006 Oct; 68(4):891.e7-10. PubMed ID: 17070387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic and prognostic role of the insulin growth factor pathway members insulin-like growth factor-II and insulin-like growth factor binding protein-3 in serous effusions.
    Slipicevic A; Øy GF; Askildt IC; Holth A; Hellesylt E; Flørenes VA; Davidson B
    Hum Pathol; 2009 Apr; 40(4):527-37. PubMed ID: 19121847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic utility of D2-40 and podoplanin in effusion cell blocks.
    Bhalla R; Siddiqui MT; Mandich D; Cartun RW; Fiel-Gan MD; Nassar A; Mandavilli SR
    Diagn Cytopathol; 2007 Jun; 35(6):342-7. PubMed ID: 17497664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The expression pattern of beta-catenin in mesothelial proliferative lesions and its diagnostic utilities.
    Dai Y; Bedrossian CW; Michael CW
    Diagn Cytopathol; 2005 Nov; 33(5):320-4. PubMed ID: 16240396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.